BrainsWay Ltd. BWAY

Set alert

Price alert · BWAY

All alert types
11.09 USD -0.27 -2.38%

At close · Nov 2

11.09 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
11.00 × 2
Ask
11.09 × 2
11.00 Day range 11.51
7.14 52-week range 17.40
YTD
+16.61%
1 year
+31.55%
Open
11.41
Prev close
11.36
Mkt cap
446.41M
Vol
77.64K
Avg vol
106.91K
EPS
0.23
P/E
48.22
Div yield
0.00%
More statistics
Low
11.00
High
11.51
Forward P/E
91.50
Beta
0.37
Short ratio
0.33
Inst. own
19.22%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
9.84
200-d avg
7.41
1y target
13.73

5Y chart

Chart tools
Interval

Events in this range
  • Nov 15, 2023Earnings: —; estimate -0.07; surprise —%
  • Mar 6, 2024Earnings: —; estimate -0.03; surprise —%
  • Mar 6, 2024Earnings: 0.01; estimate -0.03; surprise 133.33%
  • Aug 6, 2024Earnings: 0.04; estimate 0; surprise —%
  • Aug 6, 2024Earnings: —; estimate 0; surprise —%
  • Aug 7, 2024Rating: Northland Capital Markets · Outperform → Outperform
  • Aug 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 16, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 3, 2024Rating: Northland Capital Markets · Outperform → Outperform
  • Oct 21, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 12, 2024Earnings: 0.04; estimate 0.01; surprise 300%
  • Dec 23, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Mar 4, 2026Split: 2 for 1
Signals (84)
NameDateAgo
SMA: BearishAug 24, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BullishJul 13, 20263 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Sell SignalJun 1, 20265 months ago
RSI: OverboughtMar 30, 20267 months ago
RSI: OverboughtMar 2, 20268 months ago
RSI: OverboughtFeb 9, 20268 months ago
MACD: Buy SignalDec 22, 202510 months ago
RSI: OverboughtDec 22, 202510 months ago
MACD: Sell SignalDec 8, 202511 months ago
MACD: Buy SignalDec 1, 202511 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BearishNov 17, 202511 months ago
SMA: BullishNov 10, 202511 months ago
MACD: Sell SignalNov 10, 202511 months ago
SMA: BearishNov 3, 20251 year ago
RSI: OverboughtOct 20, 20251 year ago
RSI: OverboughtAug 18, 20251 year ago
SMA: BullishAug 11, 20251 year ago

Newest 20 of 84.

Key statistics

Market cap
172.14M
Enterprise value
243.14M
Trailing P/E
114.38
Forward P/E
91.50
PEG ratio
0.00
Price / sales
4.73
Price / book
7.31
EPS (TTM)
0.08
Beta
0.37
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
1.67%
Revenue (TTM)
36.43M
Revenue growth
27.80%
Free cash flow
3.16M
Total cash
47.86M
Total debt
0
Return on equity
1.44%
Shares outstanding
18.81M
Short % of float
0.33%
50-day average
9.84
200-day average
7.41

Financials — quick view

All financials
BWAY Revenue — quarterly 17.11M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BWAY Net income — quarterly 2.71M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BWAY EPS — quarterly 0.07
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

BWAY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 20240.010.04+0.03+300.00%
Aug 6, 2024Jun 1, 20240.000.04——
Aug 6, 2024Jun 1, 20240.00———
Mar 6, 2024Dec 1, 2023-0.03———
Mar 6, 2024Dec 1, 2023-0.030.01+0.04+133.33%
Nov 15, 2023Sep 1, 2023-0.07———

Upgrades / downgrades

BWAY analyst upgrades and downgrades
DateFirmActionFromTo
Dec 23, 2024HC Wainwright & Co.reitBuyBuy
Oct 21, 2024HC Wainwright & Co.reitBuyBuy
Oct 3, 2024Northland Capital MarketsmainOutperformOutperform
Sep 16, 2024HC Wainwright & Co.reitBuyBuy
Aug 8, 2024HC Wainwright & Co.mainBuyBuy
Aug 7, 2024Northland Capital MarketsmainOutperformOutperform

About BrainsWay Ltd.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Sector
Healthcare
Industry
Medical Devices
Country
Israel

News

Your note

Sign in to keep a note on BWAY — it syncs with the Stock Master app.

Institution ownership

BWAY institution ownership
Holder% heldSharesValueReported
Masters Capital Management, LLC4.78%900,0008.23MSep 29, 2024
Renaissance Technologies, LLC1.92%361,1603.30MSep 29, 2024
Essex Investment Management Co LLC1.85%347,7613.18MSep 29, 2024
Acadian Asset Management. LLC1.57%295,1422.70MSep 29, 2024
DAFNA Capital Management, LLC1.34%251,3462.30MSep 29, 2024
Phoenix Holdings Ltd.1.28%240,3582.20MSep 29, 2024

Fund ownership

BWAY fund ownership
Holder% heldSharesValueReported
ARK ETF Tr-ARK Israel Innovative Technology ETF1.07%201,6701.85MOct 30, 2024
1290 Fds-1290 Essex Small Cap Growth Fd0.33%61,736564.88KJul 30, 2024
Trust for Professional Managers-ActivePassive International Equity ETF0.18%33,784309.12KAug 30, 2024
Perritt Ultra MicroCap Fund0.11%20,000183.00KJul 30, 2024
Voya International Small Cap Fund0.03%4,91744.99KSep 29, 2024
Fidelity NASDAQ Composite Index Fund0.03%5,01245.86KOct 30, 2024